Alere continues rebuild with sale of BBI and acquisition of US Diagnostics

Alere's ongoing restructuring effort, intended to refocus on core businesses and regain investor confidence, continued July 16 with the agreement to sell its BBI division and acquire US diagnostics.

More from Archive

More from Medtech Insight